Target RWE launches new analytical solutions to advance real-world evidence generation

New solutions by Target RWE, Syndicated Science™ Insights, offer users access to robust analytics of large claims databases and are designed to address research hypotheses regardless of the data source. 

Target RWE, a real-world evidence (RWE) company providing data, analytics, and consulting services to pharmaceutical, life sciences, and healthcare organizations, has announced a new suite of analytical solutions to advance the generation of RWE. The Syndicated Science Insights (SSI) suite of analytical solutions provides users with advanced analytics generated from a variety of RWD sources, including Target RWE’s proprietary patient communities and large claims databases, electronic health records data, and other linked data sources.  

Three solutions are available within the SSI suite: Market Insights, Community Insights, and Customized Insights. Each solution contains multiple data insights across a product’s lifecycle and therapeutic indications, including target population characterization, such as incidence/prevalence of disease to forecast the size of addressable populations as well as identify patient subgroups, trend monitoring for policy evaluation and causal inference for principled safety monitoring and comparative effectiveness research. Users have access to interactive data visualizations and all scientific content can be updated, edited, and revised over time to take into account evolving research questions, new data, and emerging healthcare guidance. 

Derek Evans, Target RWE Chief Executive Officer said in the company’s press release, “Our novel group of robust analytical solutions represents a giant leap forward in real-world evidence analysis, and we are thrilled to see how it will drive transformative advancements in patient care, drug development, and healthcare decision making.” 

Jennifer Christian, Chief Scientific Officer, continued, “Our Syndicated Science Insights products underscore our commitment to harness advanced technologies and provide an easy-to-use, convenient solution that can be customized to address specific topics of interest.”  

Target RWE are currently attending the International Society for Pharmacoepidemiology (ICPE) 39th annual meeting in Halifax, Canada, August 23–27, 2023, where they are offering live demonstrations of the Market Insights tool and presenting innovative research surrounding advanced methods in the field of epidemiology and statistics.